Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis.
Nham E, Sohn JW, Choi WS, Wie SH, Lee J, Lee JS, Jeong HW, Eom JS, Choi YJ, Seong H, Yoon JG, Noh JY, Song JY, Cheong HJ, Kim WJ.
Nham E, et al. Among authors: lee js, lee j.
Front Immunol. 2024 May 13;15:1382944. doi: 10.3389/fimmu.2024.1382944. eCollection 2024.
Front Immunol. 2024.
PMID: 38803497
Free PMC article.